Today: 9 June 2026
Browse Category

Technology 8 June 2026 - 9 June 2026

Cerebras Jumps Again After Wall Street Calls Its AI Chip a Rival for Nvidia

Cerebras Jumps Again After Wall Street Calls Its AI Chip a Rival for Nvidia

Cerebras Systems surged 18.32% Monday and jumped another 3.66% premarket to $246.53 after at least nine Wall Street banks launched bullish coverage, spotlighting the AI-chip maker’s rapid rise as a public-market test for AI hardware demand beyond Nvidia, with investor focus on its massive OpenAI deal and AWS partnership—but risks loom if OpenAI demand shifts or rivals defend their turf.
9 June 2026
···
Marvell Joins S&P 500 But AI Chip Gains Come With a Twist

Marvell Joins S&P 500 But AI Chip Gains Come With a Twist

Marvell Technology surged 9.6% to $288.85 after being picked for the S&P 500, extending a 59% rally since May 27, as passive funds prepare to buy shares before its June 22 entry; the move follows record revenue, strong AI bookings, and Nvidia’s $2 billion investment, but risks remain after a recent sector selloff and warnings of overbought conditions.
9 June 2026
····
OpenAI IPO filing puts AI rally at center stage for Wall Street

OpenAI IPO filing puts AI rally at center stage for Wall Street

OpenAI has confidentially filed for a possible IPO, but investors won’t see key financials—including revenue quality, cash burn, and compute costs—until the S-1 goes public; with $2 billion monthly revenue and a recent $852 billion valuation, the filing signals a pivotal shift as AI giants race for public capital amid rising infrastructure costs and growing competition from Anthropic.
9 June 2026
······
SmartKem Shares Jump 100% on SRx Investment, SMTK in Focus

SmartKem Shares Jump 100% on SRx Investment, SMTK in Focus

SmartKem shares soared as much as 150% to $1.135 before settling at $0.84 after SRx Health Solutions disclosed a 4.99% stake and purchase of convertible preferred securities, injecting new investor interest as SmartKem faces a Sept. 1 Nasdaq delisting risk for trading below $1 and warns of “substantial doubt” about its ability to continue as a going concern.
8 June 2026
·
Ondas Stock Comes Back Into the Spotlight After 13% Drop; Drone Trade Faces Fresh Challenge

Ondas Stock Comes Back Into the Spotlight After 13% Drop; Drone Trade Faces Fresh Challenge

Ondas shares slipped 0.5% to $10.38 as investors weighed a new $4.8M U.S. Navy-linked balloon contract and $110M in Q2 orders against high short interest (31.33% of float), rising operating losses, and fresh stock-supply concerns after a June 3 filing revealed more Omnisys-related shares could hit the market, raising dilution risks despite surging revenue and backlog.
8 June 2026
···
ASML Sets New European Valuation Record; Broadcom Shows Risks in AI

ASML Sets New European Valuation Record; Broadcom Shows Risks in AI

ASML’s market value soared to a European record of $691.8 billion as analysts raised estimates for its EUV machine output, driving U.S. shares up 7.1% after JPMorgan and Morgan Stanley hiked price targets, with investors betting on ASML’s control of critical chipmaking tools amid surging AI demand and factory expansions planned for 2026.
8 June 2026
····
1 2 3 … 236

Stock Market Today

  • Washington's Railroad Rule Changes Threaten U.S. Supply Chain
    June 9, 2026, 9:15 AM EDT. Congress and the White House are quietly imposing new regulations on U.S. railroads, a critical component of the national economy. These changes, seen as micromanagement, could disrupt freight movement and supply chains. The timing raises concerns amid ongoing economic pressures and recovery efforts post-pandemic. Rail networks handle bulk goods and industrial materials vital to commerce. Industry experts warn that increased federal oversight may hinder operational efficiency and investment. Delays or inefficiencies in rail transport could ripple through markets, affecting costs and delivery times across sectors. Stakeholders urge a balanced approach to regulation to ensure infrastructure resilience without stifling rail companies' flexibility and growth.

Latest articles

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
AmpliTech’s 5G Radio Test Moves AMPG Shares

AmpliTech’s 5G Radio Test Moves AMPG Shares

9 June 2026
AMPG soared 26.7% to $6.57 after AmpliTech revealed its 64T64R Massive MIMO radio was the only one of its kind at O-RAN PlugFest, showing interoperability with major carriers’ equipment, but no new orders were announced, leaving sales conversion as the key investor focus.
Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

9 June 2026
Factorial Energy surged 16% to $13.80 in its Nasdaq debut as FAC, with premarket trading near $20.70, after replacing CGCT via SPAC merger that raised over $100 million for battery commercialization and implied a $1.3 billion equity value; former CGCT shares now trade as FAC, with founders retaining majority voting power and staged lock-up releases ahead.
Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

9 June 2026
Pfizer shares fell 1.7% premarket to $25.62 as investors weighed an FDA label expansion for hemophilia drug Hympavzi—now the first subcutaneous non-factor therapy for children 6-11 with hemophilia B—against slower progress in obesity drugs, with mid-stage data for weight-loss shot berobenatide showing a 23.3% vomiting rate and no immediate growth catalyst for the $147 billion company.
Snap Shares Fall Even as Nasdaq Gains; June 16 in Focus

Snap Shares Fall Even as Nasdaq Gains; June 16 in Focus

9 June 2026
Snap Inc. shares fell 1.9% to $5.65, underperforming a rising Nasdaq and leaving the stock 46% below its 52-week high, as investors weigh weak ad revenue growth, North American user declines, and cost-cutting moves against ongoing competitive pressure from Meta and TikTok.
Go toTop